You are here: Industry Insights > china

News List

Fertility specialist clinic open in Beijing biospectrumasia
May 31, 2017
Ciming has invested in Global Fertility & Genetics of New York. The reproductive endocrinology and infertility center specializes in customized fertility treatment.
Shanghai Fosun Pharmaceutical Group, Shandong Buchang Pharmaceutical, 4SC pharmaceutical-technology
May 27, 2017
Shanghai Fosun Pharmaceutical Group intends to raise approximately HK$2.32bn ($298.3m) through a private placement of 80.6 million shares.
Athenex and Its Partner, Guangzhou Xiangxue Pharmaceutical, Announced Chinese FDA IND Approval to Be en-cphi.cn
May 25, 2017
Athenex, Inc., Buffalo, NY announced Guangzhou Xiangxue Pharmaceutical Co. Ltd., (Xiangxue) has received the Chinese FDA Investigational New Drug (IND) approval to begin clinical trials for...
Merck's Gardasil preps for head-to-head with GlaxoSmithKline’s Cervarix in China, with big sales tar fiercepharma
May 25, 2017
GlaxoSmithKline's Cervarix may have been the first HPV shot approved in mainland China, but Merck's Gardasil now has an opening to gain the lead.
Boehringer Ingelheim inaugurates biopharmaceutical manufacturing facility in China cphi-online
May 25, 2017
It is the first and only biopharmaceutical manufacturing site established by a multinational active pharmaceutical company in China.
Boehringer opens biopharmaceutical manufacturing facility in China pharmaceutical-technology
May 18, 2017
Germany’s Boehringer Ingelheim has officially opened its commercial production site for biopharmaceuticals in Zhang Jiang Hi-tech Park in Shanghai, China.
Sinovac Biotech Announces Receipt of NASDAQ Letter and Delayed Filing of Annual Report on Form 20-F en-cphi.cn
May 17, 2017
Sinovac Biotech Ltd. announced today that it is delaying its Annual Report on Form 20-F for the year ended December 31, 2016 (the "2016 Annual Report") and that it received a written notice from the Listing Qualifications Department of The Nasdaq Stock Ma
Boehringer Ingelheim inaugurates world-class biopharmaceutical manufacturing facility in China worldpharmanews
May 17, 2017
Boehringer Ingelheim inaugurated its commercial production site for biopharmaceuticals in Zhang Jiang Hi-tech Park of Shanghai (China).
QIAGEN partners with Maccura to localize and commercialize GeneReader NGS System in China pharmaasia
May 17, 2017
Partnership with a leading Chinese IVD company with goal to accelerate penetration of the world’s first complete Sample to Insight NGS solution in rapidly growing Chinese market.
China threatens prison time and death penalty to fight fraudulent trial pharmafile
May 15, 2017
In a drastic move to help solve its notorious problem with fraudulent clinical trial data, China has introduced a policy shift in its criminal code meaning that persons wilfully submitting fake data will be imprisoned or even executed.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page